surmount-1 tirzepatide non-diabetic weight loss trial obesity without diabetes once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 Gastrointestinal tolerability and reduction – www 🤔Adults with type 2 diabetes

Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial [published correction appears in Arch Ophthalmol 1998 Nov;116(11):1469]

Your body has adapted to the current dose, and the jump to a higher level creates a new, unfamiliar peak concentration

Central effects of glucagon The first evidence pointing to a role of the brain in glucose metabolism dates back to the work of Claude Bernard, who in 1854 showed that puncturing the floor of the fourth ventricle increases blood glucose in rodents [86]

Not required

This indicates the injection is finished

Backup freezer systems should also be in place to prevent catastrophic loss in case of equipment failure